Twitter Linkedin Youtube Campus Rubió
NEWS AND COMMUNICATIONS

Spain’s Universal Healthcare and Pharma: A Synergistic Overview

Overview of Healthcare in Spain

The healthcare system in Spain is publicly funded, universally accessible, and managed by the National Institute of Health Management (INGESA). Spain ranks among the top OECD countries for clinical outcomes,

Spain ranks among the top OECD countries for clinical outcomes, supported by its universal coverage and emphasis on equity. Life expectancy at birth in Spain reached 83.2 years in 2022, compared to the OECD average of 81.0 years. Infant mortality is among the lowest in Europe, at just 2.5 deaths per 1,000 live births, well below the OECD mean of 4.1. Moreover, around 99% of the Spanish population is covered by the public health system, ensuring broad and equitable access to medical services. This combination of efficiency, accessibility, and strong public trust places Spain consistently within the top quartile of OECD nations for health system performance.

These figures are drawn from official sources, including the OECD’s Health at a Glance: Europe 2024 report, the Spanish Ministry of Health, and the World Health Organization.

How is healthcare in Spain?

With 99.5% of the population enjoying universal access through the public health system. Life expectancy is the highest in the EU, at 83.5 years in 2024, reflecting excellent management of chronic diseases and preventive services. Patient satisfaction is also high; 86% of people with chronic conditions rate care quality as good and 85% describe their care as person-centered, based on OECD PaRIS surveys. Spain’s hospitals perform 3.5 million surgical interventions annually, with nearly 87 million public sector consultations each year, and 48.6% of major surgeries are conducted on an outpatient basis, highlighting system efficiency.

These outcomes are documented by sources such as the OECD Health at a Glance: Europe 2024 report, the OECD PaRIS patient survey, and the Spanish Ministry.

Does Spain have universal healthcare?

Yes, Spain guarantees universal healthcare for all residents, funded through general taxation. Services are delivered through autonomous communities, ensuring equitable access regardless of income or region.

  • Spain’s equity-based model delivers care across all income levels
  • Ranked in the top tier of OECD countries for efficiency and clinical performance
  • Strong emphasis on preventative care and public health programs

Public vs. Private Healthcare in Spain

Spain’s public health system ensures free or low-cost healthcare for all legal residents. It is primarily funded through general taxation and administered regionally by the autonomous communities. The system guarantees universal access to essential services, including primary care, hospital admissions, and emergency treatment, which account for over 70% of total healthcare spending. According to the Federación de Asociaciones para la Defensa de la Sanidad Pública (FADSP),, Spain consistently ranks among the top European countries in terms of equity and accessibility, although regional differences can affect waiting times and resource allocation.

In parallel, Spain’s private healthcare sector complements the public system by offering faster access to specialists, shorter waiting lists for elective procedures, and more comfort-oriented services. Approximately 20% of the population hold private insurance to take advantage of these benefits.

Is healthcare free in Spain?

Yes, healthcare in Spain is free at the point of use for residents for most services. Prescription medications require a co-payment that varies by income and employment status. Active workers with incomes below €18,000 pay 40% of the medication cost, those earning between €18,000 and €100,000 pay 50%, and those with incomes above €100,000 pay 60%. Pensioners generally pay 10% with monthly caps that vary according to income, with exemptions for vulnerable groups and those with very low incomes. This co-payment system was reformed in 2012 to link contributions to income, improving fairness and sustainability.

Sources: Spanish Ministry of Health Royal Decrees (RDL 16/2012 and RDL 20/2020)

  • The public system relies on general practitioners (GPs) for care coordination and referrals
  • Private healthcare is often used to bypass public waitlists for diagnostic tests and elective procedures
  • Many residents use dual coverage, combining public access with private insurance for added flexibility

Healthcare in Spain for expats often involves both public registration and supplemental private insurance. Expats with a valid NIE (Número de Identidad de Extranjero) and social security registration are eligible to access the public system.

Healthcare in Spain for tourists is accessible through the European Health Insurance Card (EHIC) for EU/EEA nationals, covering medically necessary treatments during short stays. Non-EU tourists typically rely on private travel insurance or pay out-of-pocket for services.

  • Over 20% of the population also uses private services, especially in urban regions like Madrid and Barcelona.
  • The co-existence of public and private healthcare contributes to Spain’s reputation for patient-centered, high-performing healthcare delivery.

Insurance & Coverage Options

The healthcare system in Spain provides universal access to public healthcare for residents, while also supporting private insurance for added convenience and non-residents.

Healthcare in Spain for expats

Expats legally residing in Spain can access public healthcare by registering with the social security system (Seguridad Social) and obtaining a healthcard (Tarjeta Sanitaria).

  • An NIE number and proof of residence are required for public enrollment
  • Once registered, expats receive the same healthcare entitlements as Spanish citizens
  • Many expats also purchase private insurance to access bilingual doctors and faster diagnostics

Non-EU Citizens and Insurance Requirements

Non-EU citizens must show proof of private health insurance to obtain a residency permit. The insurance must cover 100% of medical expenses without co-payments, as per Spanish immigration law.

  • Most private plans range from €50 to €200/month depending on age and coverage
  • Top providers include Sanitas, Adeslas, DKV, and Asisa

Temporary Visitors and Tourists

EU citizens can use the EHIC card to receive public healthcare during short stays in Spain. Non-EU visitors must rely on private travel insurance or pay directly for care.

Legal Protections and Patient Rights

All individuals using healthcare services in Spain—public or private—are protected under This legislation guarantees:

  • Informed consent before procedures
  • Confidentiality of medical records
  • The right to timely care and clear communication in one’s language
  • Access to complaints mechanisms in case of disputes

Quality of Care & Patient Rights

Spain’s healthcare system is globally recognized for its exceptional clinical outcomes, robust medical infrastructure, and high standards in patient rights and protections. Public hospitals and private clinics are equipped with modern technology, and Spain consistently invests in the training of healthcare professionals through its top-ranked medical universities.

  • The healthcare system in Spain is staffed by a well-trained nursing and medical workforce
  • Spain’s hospital infrastructure meets EU standards, with widespread access to digital tools and integrated care pathways
  • Medical education in Spain emphasizes continuous professional development, ensuring a qualified and updated healthcare workforce

Clinical Outcomes and Specialties

Spain ranks in the top tier of EU countries for clinical outcomes in key specialties such as cardiology, oncology, preventive care, and chronic disease management. It has one of the lowest avoidable mortality rates in Europe, with 143 preventable deaths per 100,000 population and 62 treatable deaths per 100,000, both below the EU average, according to data from 2020. Cardiovascular diseases remain the leading cause of death (around 33.7% of total deaths), followed closely by cancers, which accounted for 25.9% of deaths in recent years. Cancer survival rates in Spain are comparable to those in Germany and France, reflecting high-quality oncology care.

Preventive care is robust, with state-funded vaccination programs and widespread availability of screening services such as colorectal and breast cancer screenings. These efforts contribute to Spain’s sustained high life expectancy and strong management of chronic conditions like diabetes and respiratory diseases. The country also demonstrates low rates of avoidable hospitalizations, reflecting efficiency in primary and specialized care.

These health outcomes are supported by comprehensive monitoring and public health interventions, making Spain a leading example within the EU for clinical care quality and preventive health services.

Patient Rights and Access

All residents and legal users of the public or private healthcare systems in Spain are protected under Spain’s General Health Law (Ley 14/1986, de 25 de abril) and the Patients’ Rights Charter. These laws guarantee:

  • The right to clear, respectful communication in the patient’s preferred language
  • Access to a second medical opinion when necessary
  • Electronic health records (EHRs) accessible across all public facilities, which support continuity of care
  • The right to privacy and the protection of personal health information

These protections are embedded in Spain’s legal framework to ensure patient autonomy, confidentiality, and high standards of care. The full text of the General Health Law is available here: https://www.boe.es/buscar/act.php?id=BOE-A-1986-10499

Detailed patient rights and duties are also outlined in the Patients’ Rights Charter, which emphasizes informed consent, non-discrimination, and the right to be truthfully informed in understandable terms. The legislation governs privacy and data protection regarding health records in line with EU regulations, facilitating safe and secure use of EHRs across the National Health System

Does Spain have a good healthcare system?

Yes, Spain has one of the best healthcare systems in Europe, characterized by universal access, low out-of-pocket expenses, and excellent clinical results across multiple specialties. The country is consistently ranked highly by major organizations:

  • According to the World Health Organization (WHO), Spain has the highest life expectancy in the European Union, exceeding 83 years, and maintains one of the lowest avoidable mortality rates in Europe WHO Spain Health System Review 2024.
  • The OECD ranks Spain highly for health system performance, especially regarding patient satisfaction, care coordination, and chronic disease management. Approximately 86% of patients with chronic conditions rate the quality of care as good, and 89% trust their primary care providers, figures that align well with OECD averages OECD Spain Report 2025.
  • Spain operates a dual public-private healthcare system, where the public system guarantees broad access while the private sector offers faster access and more choice for those with private insurance (held by about 28% of residents).
  • Wait times in the public system are moderate and managed through this synergy with the private sector.

Spain’s strong commitment to patient-centered care, health equity, and continuous quality improvement has established it as a leader in global health service delivery, recognized by both WHO and OECD rankings.

Behavioral & Mental Health Services in Spain

The Spain behavioral health services market is growing through public investment and private care expansion. Mental health is increasingly integrated into the Spain public health system, with access to psychologists, psychiatrists, and community programs.

  • Public centers provide mental health services through general practitioner referrals.
  • Spain’s national mental health strategy emphasizes early intervention and youth support.
  • Government funding supports telehealth and equity-focused programs.

This dual model ensures broader access and supports Spain’s progress toward integrated, accessible behavioral care.

Popular Treatments and Medical Technologies

Spain delivers advanced care in oncology, cardiology, and neurology through well-equipped public hospitals and a thriving private sector. Hospitals utilize robotic surgery, MRI/PET imaging, and genetic therapies for cancer and rare diseases, showcasing advanced medical technologies. The country’s biotechnology sector is robust, with over 800 companies contributing to personalized medicine and diagnostics, according to ASEBIO 2023. The total addressable market (TAM) for biotechnology in Spain is significant with a compound annual growth rate (CAGR) estimated at around 7–9%, reflecting strong sector expansion.

Pharmaceutical exports from Spain reached approximately €18.18 billion in 2024, maintaining Spain’s position among the top exporters in Europe. According to Farmaindustria 2023 data, Spain ranks 5th in pharmaceutical exports within the European Union, trailing major exporters like Germany and Belgium but ahead of countries such as Italy and the Netherlands.

These innovations and exports not only support clinical excellence across key specialties but also strengthen Spain’s economic competitiveness in the global healthcare and pharmaceutical markets.

Sources:

Availability of Medications in the Public Health System

Spain’s public health system ensures broad access to essential medications through a well-regulated and equitable framework. The Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) plays a central role in overseeing the approval, safety, and pricing of pharmaceuticals, ensuring that all medications meet strict standards of efficacy, safety, and cost-effectiveness.

Prescription Medications and Subsidies

Prescription drugs in Spain are heavily subsidized by the government, making them accessible to most of the population. The co-payment system is income-based, with patients contributing between 10% and 60% of the medication cost depending on their income level, employment status, and age. Pensioners and individuals with chronic conditions often benefit from reduced or zero co-payments, promoting health equity.

Over-the-Counter (OTC) Medications

OTC medications are widely available through a dense network of community pharmacies, which are the primary point of access for non-prescription drugs. These pharmacies are staffed by licensed professionals who provide guidance on safe medication use, contributing to responsible self-medication practices.

Cost-Containment and Sustainability Measures

To maintain the financial sustainability of the public health system, Spain implements several cost-containment strategies, including:

  • Reference pricing systems that cap reimbursement levels for groups of similar drugs.
  • Centralized bulk procurement to negotiate lower prices with pharmaceutical companies.
  • Health technology assessments (HTAs) that evaluate both the clinical value and budgetary impact of new medications before they are approved for public funding.

Commitment to Access and Innovation

  • Spain’s approach balances universal access with fiscal responsibility, ensuring that patients receive clinically valuable treatments without compromising the long-term viability of the healthcare system. The integration of evidence-based evaluations and transparent pricing policies supports innovation while protecting public health resources.

The Role of Pharmaceutical Companies in Spain’s Healthcare

Pharmaceutical companies play a foundational role in Spain’s healthcare by advancing science, strengthening the economy, and expanding patient access.

  • The industry contributed over €26.8 billion in exports in 2022, its highest ever (Farmaindustria, 2023).
  • Spain is a European leader in clinical trials, with over 900 launched in 2022 involving 170,000 participants.
  • Major firms such as Grifols, Almirall, and Rovi lead in biologics and biosimilars.
  • Rubió focuses R&D in VAMs for Rx pharmaceuticals drugs that target low-prevalence and high prevalence disease.
  • The sector supports 270.000 puestos de trabajo en toda España—64% requiring high specialization.

This industrial strength supports not just innovation but also national health priorities and global partnerships.

Challenges in Integrating Pharma into Universal Care

Spain faces structural challenges in harmonizing universal healthcare access with rapid pharmaceutical innovation.

  • The high cost of new therapies puts pressure on public healthcare budgets
  • Drug approval processes involve multiple layers of regional and national review
  • EU patent and pricing regulations add complexity to reimbursement decisions

“Ongoing efforts are addressing these challenges, while the healthcare system continues to guarantee universal coverage for all.”

How Pharma Can Support a Sustainable Healthcare System

Pharmaceutical companies, such as Rubió, play a critical role in building a more sustainable healthcare system in Spain through investment in clinical trials, medical education, public health awareness, and environmental responsibility.

Clinical trials funded by pharma reduce the burden on the public health system by offering early access to innovative treatments.

In 2024, investment in clinical trials in Spain reached approximately €900 million, driven largely by the pharmaceutical industry, which funded over 830 million euros of this total. This significant investment supports more than 900 clinical trials authorized across the country, engaging around 170,000 patients in cutting-edge research, including studies focused on cancer, rare diseases, and advanced therapies.

For over 50 years, Rubió has invested in R&D, developing and bringing to market more than 10 medicines, including Value Added Medicines (VAMs). Beyond innovation, Rubió advances medical education by sponsoring training in digital diagnostics and emerging therapies, ensuring healthcare professionals remain equipped with cutting-edge knowledge. The company also supports public health campaigns that raise awareness on managing chronic diseases, ultimately improving outcomes and reducing long-term care costs.

Sustainability is a core pillar of Rubió’s business strategy, integrating environmental stewardship with its commitment to human health. The company prioritizes ecological impact and people’s well-being by applying circular economy principles, investing in renewable energy, and optimizing resources. Rubió’s photovoltaic panels currently generate 15% of its total energy consumption, demonstrating real progress toward net-zero emissions.

Rubió’s sustainability initiatives include:

  • Carbon-neutral logistics targets
  • Waste reduction programs aligned with ESG objectives
  • Solar-powered operations and energy-efficient infrastructure
  • Transparent environmental policies and climate action plans (Environmental Policy)

As outlined in the Rubió ESG Report, these practices not only reduce the company’s environmental footprint but also set a benchmark for responsible innovation in healthcare. Collectively, pharma’s contributions, led by examples like Rubió, enhance care quality, reduce systemic costs, and support the long-term sustainability of the healthcare system.

Emergency & Specialized Services

Spain’s emergency care is coordinated through the national 112 system, offering rapid access to ambulances and trauma care across all regions.

  • Emergency rooms are integrated into the Spain public health system, with funding from both regional and national budgets
  • Specialist services, including oncology and cardiology, typically require GP referral in the public system
  • Private care offers direct access to specialists and shorter wait times
  • Though infrastructure varies slightly by region, all hospitals meet national quality and access standards

Spain’s blend of public and private systems ensures widespread emergency readiness and specialty care.

Conclusion: A Model for Universal and Collaborative Care

With its integrated model and robust regulatory framework, Spain sets a powerful example of public-private synergy in healthcare. Approximately 99.5% of the population is covered by the public health system, which provides comprehensive access to care free at the point of delivery. Spain boasts the highest life expectancy in the European Union at 84.25 years in 2025, significantly above the EU average of 81.4 years, reflecting the strong impact of its healthcare model on citizens’ health outcomes.

Spain spends around 10.7% of its GDP on healthcare, which is below the EU average of 11%, yet produces excellent results, demonstrating high system efficiency and value for money. Public funding covers 71.6% of health expenditures, limiting direct out-of-pocket costs and protecting households from catastrophic health spending.

Compared to the United States, where life expectancy is lower (about 78.5 years) and out-of-pocket costs and insurance complexities are much higher, Spain’s system provides much broader, more equitable access without significant financial barriers. Unlike the fragmented US model, Spain’s unified public system, supported by a complementary private sector (opted by about 28% of residents), ensures timely access and strong preventive care.

This integrated approach, balancing universal coverage with innovation and patient-centered care, results in better population health, lower avoidable mortality, and high patient satisfaction, establishing Spain as a global benchmark for efficient, accessible healthcare compared to other European countries and the US.

In summary. In Spain:

  • Spain life expectancy: 84.25 years (2025) vs US: 78.5 years
  • Public coverage: 99.5% in Spain vs complex US insurance system
  • Healthcare spending: 10.7% GDP Spain vs ~18% US
  • Patient satisfaction: 86% report good quality care in Spain
  • This underscores the significant positive impact Spain’s healthcare model has on its citizens’ health and financial protection.
Scroll up
Our site uses cookies to collect information about your device and browsing activity. We use this data to improve the site, ensure security and deliver personalized content. You can manage your cookie preferences by clicking here.
Accept cookies Configure Decline cookies
Basic cookie information
This website uses cookies and/or similar technologies that store and retrieve information when you browse. In general, these technologies can serve very different purposes, such as, for example, recognizing you as a user, obtaining information about your browsing habits or personalizing the way in which the content is displayed. The specific uses we make of these technologies are described below. By default, all cookies are disabled, except for technical ones, which are necessary for the website to function. If you wish to obtain more information or exercise your data protection rights, you can consult our "Política de cookies".
Accept cookies Configure
Technical cookies needed Always active
Technical cookies are strictly necessary for our website to work and for you to navigate through it. These types of cookies are those that, for example, allow us to identify you, give you access to certain restricted parts of the page if necessary, or remember different options or services already selected by you, such as your privacy preferences. Therefore, they are activated by default, your authorization is not necessary. Through the configuration of your browser, you can block or alert the presence of this type of cookies, although such blocking will affect the proper functioning of the different functionalities of our website.
Analysis cookies
Analysis cookies are those used to carry out anonymous analysis of the behavior of web users and allow measuring user activity and creating navigation profiles in order to improve the websites.
Confirm preferences
We want everyone to have access to our medicines wherever they are, regardless of prevalence.
OUR PRODUCTS